For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Comparison

BPC-157 vs TB-500: how the literature compares them

Both names appear together in tissue-biology discussions, and both are sold as research peptides. They are different molecules with separate literatures. This page sets out what each one is, with sources.

Published 18 November 2026 · Last updated 18 November 2026

At a glance

BPC-157 and TB-500 side by side
BPC-157TB-500
What it isSynthetic pentadecapeptide, described as a stable gastric pentadecapeptideSupplier name for a synthetic peptide related to thymosin beta-4
Length15 amino acidsCommonly 7 amino acids (Ac-LKKTETQ); full-length thymosin beta-4 is 43
SequenceGEPPPGKPADDAGLVAc-LKKTETQ (thymosin beta-4 residues 17 to 23)
Formula (PubChem)C62H98N16O22C38H68N10O14 (fragment); C212H350N56O78S (thymosin beta-4)
Molecular weight1419.5 g/molAbout 889 g/mol (fragment); about 4963 g/mol (thymosin beta-4)
Background literatureSkin-wound, tendon and muscle, and central nervous system models (Seiwerth 2021; Vukojevic 2022)Actin-sequestering protein with roles in injured-tissue and corneal wound models (Goldstein 2005; Sosne 2007)

BPC-157

BPC-157 is a synthetic peptide, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Reviews describe reported effects in skin-wound models (Seiwerth et al., 2021), tendon fibroblasts in culture (Chang et al., 2014) and the central nervous system. A 2025 systematic review of the musculoskeletal literature (Vasireddi et al.) included 36 studies: 35 preclinical and 1 clinical.

TB-500 and thymosin beta-4

Thymosin beta-4 is a 43-amino-acid actin-sequestering protein (Goldstein et al., 2005; Hannappel, 2007). TB-500 is not a standardised chemical name. It is commonly described as the acetylated fragment Ac-LKKTETQ, which contains the actin-binding motif at residues 17 to 23. Some suppliers list TB-500 as thymosin beta-4 acetate. The masses differ by a factor of about five, so identity is a documentation question first.

Why identity matters when comparing

A published result about thymosin beta-4 does not automatically describe a heptapeptide fragment, and the reverse is also true. Before comparing any two experiments, confirm what each vial contained. Mass spectrometry on the batch Certificate of Analysis settles it: about 889 g/mol points to the fragment and about 4963 g/mol to the full protein. Our guides on reading a COA and on HPLC and mass spectrometry explain how to check.

Reviews that cover both

Tham et al. (2026) review the investigational-peptide literature for BPC-157, thymosin beta-4 and TB-500 together, and are a useful starting point for readers who want a single survey.

Compound pages

Related

References

  1. Seiwerth S, Milavic M, Vukojevic J, et al. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol 12:627533. PubMed 34267654 · DOI
  2. Chang CH, Tsai WC, Hsu YH, et al. (2014). Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules 19:19066-77. PubMed 25415472 · DOI
  3. Vukojevic J, Milavić M, Perović D, et al. (2022). Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res 17:482-487. PubMed 34380875 · DOI
  4. Vasireddi N, Hahamyan H, Salata MJ, et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J 21:485-495. PubMed 40756949 · DOI
  5. Goldstein AL, Hannappel E, Kleinman HK (2005). Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11:421-9. PubMed 16099219 · DOI
  6. Hannappel E (2007). beta-Thymosins. Ann N Y Acad Sci 1112:21-37. PubMed 17468232 · DOI
  7. Sosne G, Qiu P, Kurpakus-Wheater M (2007). Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol 1:201-7. PubMed 19668473
  8. Tham A, Hodgkins CW, Kennedy JG (2026). Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500. J Am Acad Orthop Surg. PubMed 42937313 · DOI

Frequently asked questions

Are BPC-157 and TB-500 the same thing?

No. BPC-157 is a synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV). TB-500 is a supplier name for a synthetic peptide related to thymosin beta-4, commonly given as the heptapeptide Ac-LKKTETQ.

What is the difference in size?

BPC-157 is 1419.5 g/mol (C62H98N16O22). The commonly cited TB-500 fragment Ac-LKKTETQ is about 889 g/mol (C38H68N10O14), while full-length thymosin beta-4 is about 4963 g/mol.